|
Name |
Pistillarin
|
Molecular Formula | C21H27N3O6 | |
IUPAC Name* |
N-[4-[3-[(3,4-dihydroxybenzoyl)amino]propylamino]butyl]-3,4-dihydroxybenzamide
|
|
SMILES |
C1=CC(=C(C=C1C(=O)NCCCCNCCCNC(=O)C2=CC(=C(C=C2)O)O)O)O
|
|
InChI |
InChI=1S/C21H27N3O6/c25-16-6-4-14(12-18(16)27)20(29)23-10-2-1-8-22-9-3-11-24-21(30)15-5-7-17(26)19(28)13-15/h4-7,12-13,22,25-28H,1-3,8-11H2,(H,23,29)(H,24,30)
|
|
InChIKey |
ZQCQBKSAEOIDQN-UHFFFAOYSA-N
|
|
Synonyms |
Pistillarin; N-(3-((4-(3,4-Dihydroxybenzamido)butyl)amino)propyl)-3,4-dihydroxybenzamide; 89647-69-8; starbld0030020; N-[4-[3-[(3,4-dihydroxybenzoyl)amino]propylamino]butyl]-3,4-dihydroxybenzamide
|
|
CAS | NA | |
PubChem CID | 10319809 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 417.5 | ALogp: | 1.4 |
HBD: | 7 | HBA: | 7 |
Rotatable Bonds: | 11 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 151.0 | Aromatic Rings: | 2 |
Heavy Atoms: | 30 | QED Weighted: | 0.218 |
Caco-2 Permeability: | -6.082 | MDCK Permeability: | 0.00000384 |
Pgp-inhibitor: | 0.008 | Pgp-substrate: | 0.997 |
Human Intestinal Absorption (HIA): | 0.56 | 20% Bioavailability (F20%): | 1 |
30% Bioavailability (F30%): | 1 |
Blood-Brain-Barrier Penetration (BBB): | 0.009 | Plasma Protein Binding (PPB): | 42.45% |
Volume Distribution (VD): | 1.678 | Fu: | 58.31% |
CYP1A2-inhibitor: | 0.128 | CYP1A2-substrate: | 0.076 |
CYP2C19-inhibitor: | 0.08 | CYP2C19-substrate: | 0.047 |
CYP2C9-inhibitor: | 0.049 | CYP2C9-substrate: | 0.178 |
CYP2D6-inhibitor: | 0.031 | CYP2D6-substrate: | 0.237 |
CYP3A4-inhibitor: | 0.03 | CYP3A4-substrate: | 0.041 |
Clearance (CL): | 12.479 | Half-life (T1/2): | 0.894 |
hERG Blockers: | 0.225 | Human Hepatotoxicity (H-HT): | 0.06 |
Drug-inuced Liver Injury (DILI): | 0.12 | AMES Toxicity: | 0.094 |
Rat Oral Acute Toxicity: | 0.038 | Maximum Recommended Daily Dose: | 0.026 |
Skin Sensitization: | 0.941 | Carcinogencity: | 0.017 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.012 |
Respiratory Toxicity: | 0.053 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC001579 | 0.384 | D0V7XF | 0.404 | ||||
ENC000107 | 0.311 | D06KYN | 0.367 | ||||
ENC002584 | 0.309 | D0U3YB | 0.358 | ||||
ENC001998 | 0.303 | D0A6KR | 0.333 | ||||
ENC003644 | 0.302 | D0R3JB | 0.318 | ||||
ENC005040 | 0.295 | D00KRE | 0.309 | ||||
ENC002362 | 0.284 | D0Y7PG | 0.302 | ||||
ENC004765 | 0.284 | D0KN2M | 0.294 | ||||
ENC000002 | 0.284 | D0J7RK | 0.292 | ||||
ENC003620 | 0.282 | D04AIT | 0.279 |